The impact of health expenditures on public health in BRICS nations

被引:90
作者
Jakovljevic, Mihajlo [1 ]
Timofeyev, Yuriy [2 ]
Ekkert, Natalia V. [3 ]
Fedorova, Julia V. [4 ]
Skvirskaya, Galina [3 ]
Bolevich, Sergey [5 ]
Reshetnikov, Vladimir A. [3 ]
机构
[1] Lund Univ, Div Hlth Econ, SE-22007 Lund, Sweden
[2] Natl Res Univ, Higher Sch Econ, Moscow 101000, Russia
[3] Sechenov First Moscow State Med Univ, Dept Hlth Care & Publ Hlth, Moscow 119991, Russia
[4] Sechenov First Moscow State Med Univ, Ctr Master Programs, Moscow 119991, Russia
[5] Sechenov First Moscow State Med Univ, Dept Human Pathol, Moscow 119991, Russia
关键词
DISEASES; BURDEN;
D O I
10.1016/j.jshs.2019.09.002
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:516 / 519
页数:4
相关论文
共 19 条
[1]  
[Anonymous], GLOB HLTH EXP DAT
[2]   Tackling inequitable public health burden of emerging and neglected diseases in BRICS countries [J].
Ernest, T. ;
Xu, J. ;
Gao, S. ;
Chen, J. -H. ;
Hei, W. ;
Perelet, R. ;
Birtkoltz, L. M. ;
Xiaonong, Z. .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 21 :234-235
[3]  
Igbal G., 2019, 2019 INT C CONT ED S
[4]  
Jakovljevic M. B., 2014, Serbian Journal of Experimental and Clinical Research, V15, P139, DOI [10.2478/sjecr-2014-0018, 10.5937/sjecr15-6706, DOI 10.2478/SJECR-2014-0018]
[5]   Evolving Health Expenditure Landscape of the BRICS Nations and Projections to 2025 [J].
Jakovljevic, Mihajlo ;
Potapchik, Elena ;
Popovich, Larisa ;
Barik, Debasis ;
Getzen, Thomas E. .
HEALTH ECONOMICS, 2017, 26 (07) :844-852
[6]   BRIC's growing share of global health spending and their diverging pathways [J].
Jakovljevic, Mihajlo B. .
FRONTIERS IN PUBLIC HEALTH, 2015, 3
[7]   Growing burden of non-communicable diseases in the emerging health markets: the case of BRICS [J].
Jakovljevic, Mihajlo B. ;
Milovanovic, Olivera .
FRONTIERS IN PUBLIC HEALTH, 2015, 3
[8]  
Korotayev A, 2015, CRITICAL 10 YEARS DE, P125
[9]  
Kose A., 2017, Big emerging market economies versus the G7: Which group will drive the upswing in global growth?
[10]  
Menon S., 2019, J APPL PHARM SCI, V9, P135